Оценка факторов риска хирургического лечения колоректального рака у пациентов с коморбидными заболеваниями

Максименков А.В., Виноградов А.В., Трошина А.А.

Колоректальный рак (КРР) является четвертым по частоте заболеваемости и третьим по частоте смертности от онкологических заболеваний в мире. Его частота заболеваемости КРР увеличивается с возрастом. По данным литературы коморбидность увеличивает риск осложнений хирургического лечения КРР (так, по некоторым данным частота несостоятельности анастомоза у больных с коморбидными заболеваниями увеличивается на 82%, а также отмечается увеличение 30-дневной послеоперационной летальности в первые 30 суток до 6,0%). В связи с этим необходимо вырабатывать определенные подходы (всестороннее обследование больных на дооперационном этапе, решение вопроса о формировании первичного анастомоза и превентивной кишечной стомы) к профилактике послеоперационных осложнений у данной группы пациентов.

1. Cancer TODAY | IARC. https://gco.iarc.who.int/today. Data version: Globocan 2022 (version 1.1).

2. Злокачественные новообразования в России в 2023 году (заболеваемость и смертность) / Под редакцией А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. – Москва, 2024.

3. Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021; 14(10): 101174. doi: 10.1016/j.tranon.2021.101174.

4. Qiu H, Wang L, Zhou L, Wang X. Comorbidity Patterns in Patients Newly Diagnosed With Colorectal Cancer: Network-Based Study. JMIR Public Health Surveill. 2023; 9: e41999. doi: 10.2196/41999.

5. Sarfati D, Hill S, Blakely T, et al. The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study. BMC Cancer. 2009; 9: 116. doi: 10.1186/1471-2407-9-116.

6. Трошина А.А., Андреев М.А., Стойко Ю.М., Максименков А.В. «Смертельная» коморбидность – сердечно-сосудистые заболевания и онкология: общие патогенетические аспекты (часть I) // Лечебное дело. – 2023. – №1. – С.6-11.

7. Basso C, Gennaro N, Dotto M, et al. Congestive heart failure and comorbidity as determinants of colorectal cancer perioperative outcomes. Updates Surg. 2022; 74(2): 609-617. doi: 10.1007/s13304-021-01086-4.

8. Cuthbert CA, Hemmelgarn BR, Xu Y, Cheung WY. The effect of comorbidities on outcomes in colorectal cancer survivors: a population-based cohort study. J Cancer Surviv. 2018; 12(6): 733-743. doi: 10.1007/s11764-018-0710-z.

9. O’Neill C, Donnelly DW, Harbinson M, et al. Survival of cancer patients with pre-existing heart disease. BMC Cancer. 2022; 22(1): 847. doi: 10.1186/s12885-022-09944-z.

10. Boakye D, Walter V, Jansen L, et al. Magnitude of the Age-Advancement Effect of Comorbidities in Colorectal Cancer Prognosis. J Natl Compr Canc Netw. 2020; 18(1): 59-68. doi: 10.6004/jnccn.2019.7346.

11. Kellokumpu I, Kairaluoma M, Mecklin JP, et al. Impact of Age and Comorbidity on Multimodal Management and Survival from Colorectal Cancer: A Population-Based Study. J Clin Med. 2021; 10(8): 1751. doi: 10.3390/ jcm10081751.

12. Feng Y, Jin H, Guo K, et al. Causes of Death After Colorectal Cancer Diagnosis: A Population-Based Study. Front Oncol. 2021; 11: 647179. doi: 10.3389/fonc.2021.647179.

13. Chen Y, He L, Lu X, et al. Causes of death among early-onset colorectal cancer population in the United States: a large population-based study. Front Oncol. 2023; 13: 1094493. doi: 10.3389/fonc.2023.1094493.

14. Kuiper JG, van Herk-Sukel MPP, Lemmens VEPP, et al. Risk of heart failure among colon and rectal cancer survivors: a population-based case-control study. ESC Heart Fail. 2022; 9(4): 2139-2146. doi: 10.1002/ehf2.13923.

15. Sarfati D, Hill S, Blakely T, et al. The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study. BMC Cancer. 2009; 9: 116. doi: 10.1186/1471-2407-9-116.

16. Hahn EE, Gould MK, Munoz-Plaza CE, et al. Understanding Comorbidity Profiles and Their Effect on Treatment and Survival in Patients With Colorectal Cancer. J Natl Compr Canc Netw. 2018; 16(1): 23-34. doi: 10.6004/jnccn.2017.7026.

17. Boakye D, Nagrini R, Ahrens W, et al. The association of comorbidities with administration of adjuvant chemotherapy in stage III colon cancer patients: a systematic review and meta-analysis. Ther Adv Med Oncol. 2021; 13: 1758835920986520. doi: 10.1177/1758835920986520.

18. Hsieh MC, Thompson T, Wu XC, et al. The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients. Cancer Med. 2016; 5(5): 871-80. doi: 10.1002/cam4.632.

19. Snijders HS, Wouters MW, van Leersum NJ, et al. Meta-analysis of the risk for anastomotic leakage, the postoperative mortality caused by leakage in relation to the overall postoperative mortality. Eur J Surg Oncol. 2012; 38(11): 1013-9. doi: 10.1016/j.ejso.2012.07.111.

20. Paun BC, Cassie S, MacLean AR, et al. Postoperative complications following surgery for rectal cancer. Ann Surg. 2010; 251(5): 807-18. doi: 10.1097/ SLA.0b013e3181dae4ed.

21. Zaimi I, Sparreboom CL, Lingsma HF, et al. Dutch ColoRectal Audit Group. The effect of age on anastomotic leakage in colorectal cancer surgery: A population-based study. J Surg Oncol. 2018; 118(1): 113-120. doi: 10.1002/jso.25108.

22. Lin JK, Yueh TC, Chang SC, et al. The influence of fecal diversion and anastomotic leakage on survival after resection of rectal cancer. J Gastrointest Surg. 2011; 15(12): 2251-61. doi: 10.1007/s11605-011-1721-5.

23. Pommergaard HC, Gessler B, Burcharth J, et al. Preoperative risk factors for anastomotic leakage after resection for colorectal cancer: a systematic review and meta-analysis. Colorectal Dis. 2014; 16(9): 662-71. doi: 10.1111/codi.12618.

24. Lavikainen LI, Guyatt GH, Sallinen VJ, et al. ROTBIGGS Investigators. Systematic Reviews and Meta-analyses of the Procedure-specific Risks of Thrombosis and Bleeding in General Abdominal, Colorectal, Upper Gastrointestinal, and Hepatopancreatobiliary Surgery. Ann Surg. 2024; 279(2): 213-225. doi: 10.1097/SLA.0000000000006059.

25. Sugamata N, Okuyama T, Takeshita E, et al. Surgical site infection after laparoscopic resection of colorectal cancer is associated with compromised long-term oncological outcome. World J Surg Oncol. 2022; 20(1): 111. doi: 10.1186/s12957-022-02578-2.

26. Nakamura T, Mitomi H, Ihara A, et al. Risk factors for wound infection after surgery for colorectal cancer. World J Surg. 2008; 32(6): 1138-41. doi: 10.1007/s00268-008-9528-6.

27. Smith RL, Bohl JK, McElearney ST, et al. Wound infection after elective colorectal resection. Ann Surg. 2004; 239(5): 599-605; discussion 605-7. doi: 10.1097/01.sla.0000124292.21605.99.

28. Newton L, Dewi F, McNair A, et al. The community burden of surgical site infection following elective colorectal resection. Colorectal Dis. 2021; 23(3): 724-731. doi: 10.1111/codi.15420.

29. Panos G, Mulita F, Akinosoglou K, et al. Risk of surgical site infections after colorectal surgery and the most frequent pathogens isolated: a prospective single-centre observational study. Med Glas (Zenica). 2021; 18(2): 438-443. doi: 10.17392/1348-21.

30. Tian Y, Xu B, Yu G, et al. Comorbidity and the risk of anastomotic leak in Chinese patients with colorectal cancer undergoing colorectal surgery. Int J Colorectal Dis. 2017; 32(7): 947-953. doi: 10.1007/s00384-017-2798-4.

31. Gunji T, Tomita K, Koganezawa I, et al. Impact of atherosclerosis on the postoperative complications of colorectal surgery in older patients with colorectal cancer. BMC Gastroenterol. 2022; 22(1): 519. doi: 10.1186/ s12876-022-02600-7.

32. Flynn DE, Mao D, Yerkovich ST, et al. The impact of comorbidities on post-operative complications following colorectal cancer surgery. PLoS One. 2020; 15(12): e0243995. doi: 10.1371/journal.pone.0243995.

33. Marcucci M, Etxeandia-Ikobaltzeta I, Yang S, et al. Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials. BMJ. 2022; 376: e066785. doi: 10.1136/bmj-2021-066785.

34. Tong L, Xie D, Song X, et al. Is abdominal vascular calcification score valuable in predicting the occurrence of colorectal anastomotic leakage? A meta-analysis. Int J Colorectal Dis. 2020; 35(4): 641-653. doi: 10.1007/ s00384-020-03513-1.

[35. Hoek VT, Edomskis PP, Menon AG, et al. Calcification of the Aorta-Iliac Trajectory as a Risk Factor for Anastomotic Leakage in Colorectal Surgery: Individual Patient Data Meta-Analysis and Systematic Review. Surg Technol Int. 2021; 39: 155-165. doi: 10.52198/21.STI.39.CR1479.

36. Diao YH, Chen J, Liu Y, et al. Does aortic calcification really affect anastomotic leakage after rectal cancer surgery? Medicine (Baltimore). 2024; 103(28): e38860. doi: 10.1097/MD.0000000000038860.

37. Arron MNN, Broek RPGT, Adriaansens CMEM et al. Mesenteric occlusive disease of the inferior mesenteric artery is associated with anastomotic leak after left-sided colon and rectal cancer surgery: a retrospective cohort study. Int J Colorectal Dis. 2022; 37(3): 631-638. doi: 10.1007/s00384-021-04089-0.

38. Lee SY, Yeom SS, Kim CH, et al. A new aortoiliac calcification scoring system to predict grade C anastomotic leak following rectal cancer surgery. Tech Coloproctol. 2020; 24: 843-849. doi: 10.1007/s10151-020-02246-1.

[39. Postaire B, Abet E, Montigny P, Vent PA. Does the degree of calcification of the celiac trunk and superior mesenteric artery on preoperative computerized tomography predict the risk of anastomotic leak after right colectomy? A single center retrospective study. J Visc Surg. 2019; 156(3): 191-195. doi: 10.1016/j.jviscsurg.2018.10.006.

40. Knight KA, Fei CH, Boland KF, et al. Aortic calcification is associated with non-infective rather than infective postoperative complications following colorectal cancer resection: an observational cohort study. Eur Radiol. 2021; 31(6): 4319-4329. doi: 10.1007/s00330-020-07189-7.

41. Boersema GS, Vakalopoulos KA, Kock MC, et al. Is aortoiliac calcification linked to colorectal anastomotic leakage? A case-control study. Int J Surg. 2016; 25: 123-7. doi: 10.1016/j.ijsu.2015.12.008.

[42. Alekseev M, Rybakov E, Shelygin Y, et al. A study investigating the perfusion of colorectal anastomoses using fluorescence angiography: results of the FLAG randomized trial. Colorectal Dis. 2020; 22(9): 1147-1153. doi: 10.1111/codi.15037.

43. Jafari MD, Pigazzi A, McLemore EC, et al. Perfusion Assessment in Left-Sided/Low Anterior Resection (PILLAR III): A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT Near-Infrared Fluorescence Imaging in Low Anterior Resection. Dis Colon Rectum. 2021; 64(8): 995-1002. doi: 10.1097/DCR.0000000000002007.

44. Renna MS, Grzeda MT, Bailey J, et al. Intraoperative bowel perfusion assessment methods and their effects on anastomotic leak rates: meta-analysis. Br J Surg. 2023; 110(9): 1131-1142. doi: 10.1093/bjs/znad154.

45. Safiejko K, Tarkowski R, Kozlowski TP, et al. Safety and Efficacy of Indocyanine Green in Colorectal Cancer Surgery: A Systematic Review and Meta-Analysis of 11,047 Patients. Cancers (Basel). 2022; 14(4): 1036. doi: 10.3390/cancers14041036.

46. Алексеев М.В., Шелыгин Ю.А., Рыбаков Е.Г. Может ли флуорисцентная ангиография снизить частоту несостоятельности толстокишечных анастомозов? (Мета-анализ) // Колопроктология. – 2019. – №18(4). – С.139-150.

47. Bona D, Danelli P, Sozzi A, et al. C-reactive Protein and Procalcitonin Levels to Predict Anastomotic Leak After Colorectal Surgery: Systematic Review and Meta-analysis. J Gastrointest Surg. 2023; 27(1): 166-179. doi: 10.1007/s11605-022-05473-z.

48. Yang Q, Li M, Cao X, et al. An umbrella review of meta-analyses on diagnostic accuracy of C-reactive protein. Int J Surg. 2022; 104: 106788. doi: 10.1016/j.ijsu.2022.106788.

49. Лядов В.К., Гарипов М.Р., Полушкин В.Г., Тарасов Н.А., Аюпов Р.Т., Феоктистов Д.В. С-реактивный белок как ранний маркер несостоятельности швов толстокишечного анастомоза после резекции толстой кишки по поводу рака. Систематический обзор и метаанализ // Хирургия. Журнал им. Н.И. Пирогова. 2020; 8: 82-87.

50. Расулов А.О., Расулов З.Р., Мадьяров Ж.М. и др. Влияет ли уровень медицинского учреждения на непосредственные результаты хирургического лечения колоректального рака // MD-Onco. – 2022. – №2(1). – С.39-47. doi: 10.17650/2782-3202-2022-2-1-39-47.

51. Максименков А.В., Трошина А.А., Стойко Ю.М., Ботов А.В. Дифференцированный подход к хирургическому лечению больных колоректальным раком и коморбидной патологией // Вестник НМХЦ им. Н.И. Пирогова. – 2022. – №17(4-2). – С.114-120.